ARTICLE | Clinical News
Glivec regulatory update
March 5, 2012 8:00 AM UTC
The European Commission approved an expanded label for Glivec imatinib from Novartis to include the treatment of adult patients following surgical removal of stem cell factor ( SCF) receptor tyrosine...